Introduction
The Src family of tyrosine kinases (SFKs) includes eight related non-receptor kinases (Src, Yes, Fgr, Fyn, Lck, Lyn, Blk, and Hck) that regulate a variety of cellular functions including proliferation, differentiation, apoptosis, DNA synthesis, and cellular adhesion (reviewed in Erpel and Courtneidge, 1995; Thomas and Brugge, 1997) . SFKs are expressed in a variety of tissues, particularly in hematopoietic cells, and are targeted to the inner surface of the cell membrane via myristoylation or palmitoylation. Like other signal transduction molecules, SFKs share a common modular organization, consisting of five distinct regions important for protein function (Schwartzberg, 1998) . The role of Srcrelated kinases in hematopoiesis has recently been reviewed (Corey and Anderson, 1999) . In a number of hematopoietic cell lines, Src kinases are activated as a result of ligand stimulation. Among the hematopoietic cytokine receptors, Src kinase activity is essential for interleukin-5 activity and is also involved in the transfer of signals from a number of receptors, such as IL-3R, IL-6R, granulocyte colony-stimulating factor (G-CSF-R), erythropoietin (EPO-R), Prolactin (PRL-R), and B-cell antigen (BCR) (Corey et al., 1994; Anderson and Jorgensen, 1995; Hallek et al., 1997; Tilbrook et al., 1997; Fresno Vara et al., 2001; Stafford et al., 2002; Gauld and Cambier, 2004) .
Lyn kinase demonstrates unique properties acting as both a negative and positive regulator in B cells, mast cells, myeloid cells (monocytes, macrophages, eosinophils), and platelet signaling cascades (Chan et al., 1997; Baran et al., 2003; Pereira and Lowell, 2003; Maxwell et al., 2004; Hernandez-Hansen et al., 2004a) . Mice deficient in Lyn have multiple immunological defects, most notably a reduced number of peripheral B cells and defective B-cell receptor signaling (Wang et al., 1996; Cornall et al., 1998; Smith et al., 1998) . As they age, Lyn-deficient mice develop splenomegaly, produce autoantibodies, and contain elevated levels of myeloid progenitors (Nishizumi et al., 1995; Harder et al., 2001) . Furthermore, B cells isolated from lyn À/À mice display hyperactive BCR signaling, which may result in the autoimmune lupus-like phenotype described in these mice (Hibbs et al., 1995; Chan et al., 1997; Chan et al., 1998) . In macrophages, Lyn negatively regulates CSF-1 and GM-CSF (Harder et al., 2001) and lyn À/À bone marrow-derived mast cells, display a hyperproliferative response to cytokines (IL-3 and SCF), and impaired Ca 2 þ mobilization via FceRI crosslinking (Nishizumi and Yamamoto, 1997; Hernandez-Hansen et al., 2004a) .
Megakaryocytes (MKs) arise from pluripotent hematopoietic stem cells capable of differentiation into erythroid, granulocytic-macrophage and megakaryocytic lineages. MKs cell differentiation and proliferation are regulated by a number of cytokines; however, thrombopoietin (TPO) is the primary regulator of MK maturation including cellular enlargement and nuclear polyploidy. TPO binding to its cognate receptor, Mpl, results in the activation of a variety of signaling events including the Janus kinase (JAK)/signal transducer and activator of transcription (STAT), ras/raf/MAP kinase, and PI-3 kinase/Akt pathways Rojnuckarin et al., 1999; Geddis et al., 2001) . Although Mpl lacks intrinsic kinase activity, dimerization of the receptor results in a rapid increase in tyrosine phosphorylation, in large part due to the transphosphorylation and activation of JAK2 Drachman et al., 1999) . Once activated, JAK2 phosphorylates Mpl as well as numerous downstream signaling molecules (reviewed in Drachman et al., 1995; Geddis et al., 2002) . Recently, the role of SFKs in MK development has begun to be elucidated (Lannutti et al., 2003; Lannutti and Drachman, 2004) . In a previous report, we have shown that both Lyn and Fyn kinases are activated in response to TPO in primary murine MKs (Lannutti et al., 2003) . Furthermore, we have demonstrated that pharmacologic inhibitors of Src kinases enhanced TPOdependent proliferation of BaF3/Mpl cells, induce MK differentiation, and increased nuclear ploidy in cell lines as well as in primary bone marrow cells (Lannutti and Drachman, 2004; Lannutti et al., 2005) . This increase in proliferation/maturation correlates with increased intensity and duration of mitogen-activated protein kinase (MAPK) activity. Our results are consistent with previous studies that have shown that prolonged activation of MAPK is required for the maturation of MKs (Rouyez et al., 1997; Rojnuckarin et al., 1999; Filippi et al., 2002) .
Using Lyn-deficient mice, we examined the in vivo function of Lyn kinase in MK development. Our results demonstrate that lyn À/À mice contained elevated numbers of megakaryocytic progenitors as well as increased numbers of mature MKs in the spleen and bone marrow. MKs isolated from Lyn-deficient mice exhibited enhanced MAPK and Akt activity after TPO stimulation when compared to MKs isolated from wild-type mice. In contrast, SHIP-1 phosphorylation was reduced suggesting a possible link between SHIP-1 and the enhanced Akt and MAPK signaling. These data confirm that Lyn plays a negative regulatory role in vivo that is critical for the control of MK development.
Results

Lyn
À/À mice have an increased number of MKs We have previously demonstrated that whole bone marrow cells isolated and cultured from lyn À/À mice showed a greater number of high ploidy class MKs (i.e. >8N) (Lannutti and Drachman, 2004) . In order to understand the role of Lyn during MK development, we isolated femurs and spleens from 8-to 10-week-old mice. Histologic analysis revealed an increased number of MKs in both the bone marrow and spleens of lyn Figure 1 Histological analysis of bone marrow and spleen in lynfrom lyn À/À and wild-type mice (Lannutti and Drachman, 2004) .
Based on our histologic examination, we investigated whether the increase in the number of MKs results in an increase in platelet number. Interestingly, circulating platelet levels in lyn À/À mutants were slightly elevated when compared with wild-type mice (Figure 2) , although not to the same degree as the MKs. Our data are in contrast to previous studies in which it was concluded that Lyn-deficient mice have reduced platelet numbers (Harder et al., 2001) . Although MK numbers remain elevated in older mice, we observed a decrease in platelet numbers in lyn À/À mice over 12 weeks of age ( Figure 2) (Harder et al., 2001 ). An age-related decrease in platelets may be explained by peripheral destruction of platelets and/or splenic sequestration resulting in marked splenomegaly. As previously reported, lyn À/À mice develop autoimmune disease and are pancytopenic, possibly due to the result of peripheral destruction of hematopoietic cells which may be accompanied by splenic sequestration (Hibbs et al., 1995; Nishizumi et al., 1995; Chan et al., 1997; Harder et al., 2001) . (Figure 3 ). The FACS data are consistent with the changes observed in the ploidy analysis and with the histological findings in bone marrow and spleen of Lyn-deficient mice. To determine whether there was a corresponding increase in immature MK progenitors in the bone marrow and spleens of lyn À/À mice, we analyzed the number of colony-forming unit-MK progenitors (CFUMKs). Marrow and splenic cells from lyn À/À and wildtype mice were grown in vitro in semisolid media with rmIL-3, 10 ng/ml, and rmTPO; 0, 25, 50, and 75 ng/ml. Compared to wild type, CFU-MKs were significantly increased in lyn À/À mice ( Figure 4a ). Moreover, we compared the distribution of bone marrow CFU-MK sizes in the two groups, and the proportion of large colonies containing more than 25 cells was also increased in lyn À/À mice ( Figure 4b ). These results suggest that the number and proliferative potential of MK progenitors are increased in Lyn-deficient mice.
Reduced TPO-induced tyrosine phosphorylation levels in Lyn-deficient MKs To determine the mechanism by which Lyn deficiency results in an increase in the number of MKs and MK progenitors, we examined overall protein tyrosine phosphorylation of wild-type and Lyn-deficient MKs following TPO stimulation. Purified MKs from both Lyn-deficient and wild-type mice were starved for 10 h and then treated for 15 min with TPO. We found that the basal phosphotyrosine levels were comparable ( Figure 5a , lanes 1 vs 3), but there was less TPOinduced tyrosine phosphorylation in MKs from lyn 
TPO-induced Erk1/2 and Akt activity is increased in Lyndeficient MKs
Previously, in cell lines expressing the Mpl receptor, we have shown that Src kinase inhibitors PP1 and PP2 as well as a dominant-negative form of Lyn lead to increased proliferation, which was accompanied by an increase in Erk1/2 phosphorylation and activity (Lannutti and Drachman, 2004) . Based on these earlier results utilizing cell lines, we wanted to explore whether MAPK activity is affected in Lyn-deficient MKs. Stimulation with TPO induced rapid phosphorylation of MAPK in both wild-type and lyn À/À MKs. However, phosphorylation of MAPK was enhanced and persisted longer in lyn À/À MKs (Figure 6a ). At 10, 20, and 40 min MAPK phosphorylation was 2-, 2.9-, and 4-fold greater, respectively, in lyn À/À MKs (Figure 6b ). Furthermore, anti-MAPK in vitro kinase assays show that MAPK activity is upregulated in lyn À/À MKs (Figure 6c ). This confirms that Lyn kinase normally has an inhibitory effect on TPO-induced Erk1/2 activity in primary MKs.
We examined the extent of Akt phosphorylation and activation in TPO-stimulated MKs. As shown in Figure 7a , phosphorylation of Akt was more robust and sustained in TPO-stimulated lyn À/À MKs, with a 2.7-3.3-fold increase over Akt phosphorylation in the wild-type MKs. To confirm these results, we performed in vitro kinase assays by immunoprecipitating Akt from TPO-stimulated and unstimulated cells. Similar to phosphorylation, the activity of Akt is upregulated in the absence of functional Lyn (Figure 7c ). In addition, the kinetics of activation was altered, such that the peak activation of Akt occurred later in lyn À/À MKs ( Figure 7c ). Together, this is the first direct evidence using primary megakaryocytes from Lyn-deficient mice that demonstrates Lyn kinase functions as a negative regulator in Mpl/thrombopoietin signaling. Figure 5 TPO-induced signaling in wild-type and lyn À/À MKs. Bone marrow cells were harvested from mice, grown in serum-free medium with 35 ng/ml rmTPO for 3 days, and then MKs were purified using an albumin density-gradient column achieving a final enrichment of >90%. Isolated MKs were incubated in a serum-free, cytokine-free medium for 10 h and stimulated with 30 ng/ml rmTPO for 10, 20, 40 min. 5 cells are shown from assays using four mice of each genotype in triplicate. Mean values were significantly different from wild-type levels (10 ng/ml rmIL-3 and 50 ng/ml rmTPO; marrow, Pp0.01; spleen, Pp0.05). (b) After 14 days of incubation, bone marrow MK colonies were visualized by Wright-Giemsa staining and surface acetylcholinesterase activity (brown staining, original magnification, Â 300).
of Akt phosphorylation (Freeburn et al., 2002; Baran et al., 2003; Horn et al., 2004) . In addition, SHIP-1 has been demonstrated to be tyrosine phosphorylated in TPO-stimulated cell lines . To examine whether SHIP-1 is tyrosine phosphorylated in primary MKs, SHIP-1 immunoprecipitates from TPO-stimulated whole-cell lysates were probed with anti-phosphotyrosine antibody, 4G10. As shown in Figure 8 , treatment of MKs with TPO does induce phosphorylation of SHIP-1 (lanes 1-4) . Since Lyn kinase has been demonstrated to play a role in regulating SHIP-1 phosphorylation, similar immunoprecipitation experiments were performed using primary MKs from Lyn-deficient mice. In the absence of Lyn, SHIP-1 tyrosine phosphorylation was significantly lower (Figure 8) . At 10, 20, and 40 min, phosphorylation was reduced 1.8-, 2.3-, and 4.5-fold, respectively, as compared to wild-type MKs (Figure 8b ). These results suggest a possible role for Lyn in regulating SHIP-1 phosphorylation in MKs.
Discussion
In hematopoietic cells, Lyn kinase has been shown to play a role in signaling networks, both positively and negatively regulating proliferation. In this report, we have used lyn À/À mice to define the role of this kinase during megakaryocytopoiesis. Our previous studies using cell lines demonstrated that the inhibition of Lyn results in enhanced TPO-induced proliferation, suggesting that SFKs act as negative regulators of cell proliferation in this context. Our results presented in the current study confirm these findings using a genetic approach. Specifically, we have shown: (1) femurs and spleens from lyn À/À mice contained increased numbers of mature MKs and CD41/Mpl-positive cells; (2) the absence of lyn expression results in an increased number of MK progenitors; (3) MKs from Lyn-deficient mice exhibited increased, as well as prolonged, TPO-induced activation of MAPK and Akt kinase.
The biological process of megakaryocytopoiesis involves cellular proliferation and differentiation, which Increased TPO-mediated Erk1/2 phosphorylation and activation in lyn À/À MKs. Bone marrow cells were prepared and stimulated as described in the legend to Figure 5 . Cells were starved for 10 h, stimulated with 30 ng/ml rmTPO and lysates were prepared after the indicated times. (a) Samples normalized for protein concentration were resolved by SDS-PAGE, transferred onto nitrocellulose, and analyzed by immunoblotting using an antibody specific for dually phosphorylated Erk1/2 (p42/p44). Blots were stripped and reprobed with Erk1/2-specific antibody to ensure equal loading. (b) The increase in Erk1/2 phosphorylation was quantitated by densitometry, expressed as the fold change, and is representative of three separate experiments. (c) Erk1/2 kinase activity was assayed by using Elk-1 as a substrate. Elk-1 phosphorylation at Ser 383 was detected by Western blotting using a phospho-specific Elk-1 antibody. All assay data are representative of three independent experiments. ultimately leads to the production and release of platelets. During MK development, a wide variety of regulatory signals act in concert to direct terminal maturation and, during this process, the appropriate regulation of signaling thresholds are critical. Both kinases and phosphatases play imperative roles in signaling through surface receptors by regulating the state of cellular phosphorylation. In addition to the Jak/ STAT signaling pathway, TPO has been shown to stimulate Ras/Raf/MAPK, and PI3K/Akt, affecting cell survival, growth, and differentiation Rojnuckarin et al., 1999; Geddis et al., 2001) . Studies have now shown that the Src family of tyrosine kinases (SFKs) are activated and are involved in TPO signaling networks (Santini et al., 2002; Lannutti et al., 2003; Lannutti and Drachman, 2004) . In our previous studies, we have demonstrated that the inhibition of Lyn kinase results in enhanced TPO-induced proliferation and differentiation of both hematopoietic cell lines and primary megakaryocytic progenitors (Lannutti and Drachman, 2004) . The effect on cellular proliferation and differentiation correlates with an increase in Erk1/2 activity, suggesting that SFKs may negatively regulate MAPK. However, the mechanism by which SFKs are involved in these pathways remains to be defined. In this work, we found no evidence for altered JAK2, STAT3, or STAT5 phosphorylation in lyn À/À MKs. In contrast, lyn À/À MKs stimulated with TPO have increased and prolonged Erk1/2 and Akt phosphorylation and activation. Similarly, bone marrow-derived mast cells (BMMC) and B cells from lyn À/À mice shown an increased Erk1/2 and Akt phosphorylation (Chan et al., 1997 (Chan et al., , 1998 Kitaura et al., 2000; HernandezHansen et al., 2004a) , while in macrophages, Lyn deficiency lead to enhanced Akt activation (Baran et al., 2003) . It is not yet clear whether these hematopoietic cell signaling pathways function differently in MKs, but evidence suggests that SH2 domaincontaining inositol 5 0 -phosphatase (SHIP) may play a critical role in turning off both Akt and MAPK via dephosphorylation. A number of published reports have shown that a loss of Lyn activity results in the reduction of phosphorylation and activity of phosphatases, which underscores the signaling hypersensitivity observed in these deficient cell types (Harder et al., 2001; Hibbs et al., 2002; Hernandez-Hansen et al., 2004b; Beavitt et al., 2005) . Furthermore, in a number of cell types, Lyn has been demonstrated to play an important role in directly regulating SHIP-1 phosphorylation (Harder et al., 2001; Gardai et al., 2002; Hibbs et al., 2002; Baran et al., 2003) . Defects in SHIP-1 phosphorylation can be seen in Lyn-deficient B cells, BMMC, neutrophils, and macrophages. Recently, Maxwell et al. (2004) identified SHIP-1 as a negative regulator of integrin a IIb b 3 signaling in platelets. Platelets isolated from lyn À/À mice demonstrated that SHIP-1 phosphorylation is regulated through Lyn kinase. Consistent with these observations, phosphorylation of SHIP was reduced in lyn À/À MKs. Thus, identifying a relationship between Lyn and SHIP is crucial for establishing signaling thresholds in these hematopoietic cells. However, reports investigating the role of SHIP in TPO-induced Akt activation have not been studied.
Both the phosphoinositol 3-kinase/Akt and p42/p44-MAPK pathways are important for TPO-induced cellular proliferation, survival, and endomitosis. In MKs, PI3K has been shown to contribute to proliferation and cell cycle progression through its action on Akt but does not appear to be sufficient to support proliferation alone (Geddis et al., 2001) . While sustained activation of MAPK results in differentiation, transient activation does not (Racke et al., 1997; Rouyez et al., 1997) . Several pathways have been described for activation of MAPK through members of the cytokine receptor superfamily. The best described of these involves recruitment of the adapter molecules Shc and Grb2 to phosphotyrosine residues on the receptor. These proteins complex with the GDP exchange factor SOS and participate in activation of Ras at the cell membrane and the subsequent activation of Raf (MAPKKK), MEK1/2 (MAPKK), and Erk1/2 (MAPK). However, this cannot be the only pathway for MAPK activation as mutated Mpl receptors, which cannot phosphorylate Shc, are still capable of reducing Erk1/2 phosphorylation (Rojnuckarin et al., 1999) . Furthermore, a recent report demonstrates that Erk phosphorylation is normal in raf-1 À/À (knockout) mice (Kamata et al., 2004) . Lastly, in some systems, Erk1/2 has been shown to be activated directly by protein kinase C (PKC) (Ezumi et al., 1998; Cheng et al., 2001) . It is not completely understood how TPO stimulation leads to the activation of PI3K, but recent studies have begun to investigate novel signaling mechanisms in which TPO-induced MAPK activation is mediated by PI3K Rojnuckarin et al., 2001) . A potentially important step in identifying a role for Lyn in regulating SHIP-1 function would be to investigate its association with PI3K activity in lyn
MKs by assaying kinase activity and PIP3 levels. These studies are currently under investigation in our laboratory.
Our studies have demonstrated an important role for Lyn kinase in negatively regulating TPO/Mpl signaling in relation to MK proliferation and differentiation. Two possible explanations could account for these observations: (1) a loss of Lyn kinase might delay entry of CFUMKs into endomitosis, allowing extra cell divisions prior to terminal maturation resulting in a greater number of MK progenitors, and/or (2) lyn À/À MKs may have an accelerated cell cycle progression during mitosis and endomitosis. Experiments to distinguish between these two hypotheses are currently ongoing. Furthermore, this paper demonstrates that, for the first time in primary MKs, Lyn negatively regulates TPO-induced Akt and MAPK activity. Additional studies are underway to investigate the role of SHIP-1 with respect to Lyn activation. Specifically, identifying downstream targets linking Lyn activity to Akt/MAPK/SHIP-1 are areas for future studies.
Materials and methods
Antibodies
The following primary antibodies were used in these studies: anti-mouse CD41-fluorescein isothiocyanate (FITC) conjugate and anti-mouse IgG 1 -FITC conjugate (BD PharMingen, San Diego, CA, USA); monoclonal antiphosphotyrosine (4G10), polyclonal anti-JAK2, polyclonal antiphospho-JAK2 (Y1007/ Y1008), and polyclonal anti-SHIP (Upstate Biotechnology, Lake Placid, NY, USA); polyclonal antiphospho-STAT3 (Tyr 705), polyclonal anti-STAT3, polyclonal antiphospho-STAT5 (Tyr 694), polyclonal anti-STAT5, polyclonal antiphosphoMek (Ser 217/221), polyclonal anti-Mek, polyclonal antiphospho-Akt (Ser 473), polyclonal anti-Akt, polyclonal antiphospho-extracellular signal-related kinase 1 and 2 (Erk1/2), and polyclonal anti-Erk1/Erk2 (Cell Signaling Technology, Beverly, MA, USA); polyclonal Mpl antiserum (kindly provided by Amgen, Thousand Oaks, CA, USA). Secondary antibodies, horseradish peroxidase-coupled goat antimouse IgG, or goat antirabbit were purchased from Bio-Rad (Hercules, CA, USA).
Mice C57BL/J (Jackson Laboratories, Bar Harbor, ME, USA) and lyn À/À mice (generously provided by Janet Oliver, University of New Mexico, Albuquerque) were bred and housed in specific pathogen-free facilities at the University of Washington (Seattle, WA, USA). Animal experimentation was performed under an approved protocol in accordance with the University of Washington Institutional Animal Care and Use Committee (IACUC) guidelines.
Bone marrow isolation, MK cell culture and purification Bone marrow was isolated from 8-10-week-old C57BL/J and lyn À/À mice backcrossed to C57BL/J. Mice were killed and their femurs and tibias were harvested. The bone marrow was flushed from the bones with Iscove modified Dulbecco medium (IMDM) containing 2% heat-inactivated FCS. The dilute bone marrow was filtered through 70-mm mesh to remove bone particles, red blood cells (RBCs) were lysed in hypotonic buffer, and nucleated cells were counted and resuspended (1 Â 10 6 cells/ml) in IMDM supplemented with 1% Nutridoma-SP (Roche Molecular Biochemicals, Indianapolis, IN, USA), and 2 mM L-glutamine. Recombinant mTPO was added (Peprotech, Rocky Hill, NJ, USA) to achieve a final concentration of 37.5 ng/ml. After 72 h of growth (371C, 5% CO 2 , humidified incubator), mature MKs were harvested by low-speed centrifugation (400 rpm for 10 min) and purified by unit gravity sedimentation on a discontinuous bovine serum albumin (BSA) density gradient as previously described (Lannutti et al., 2003) .
Histological and platelet analysis Femurs and spleens were obtained from C57BL/J and lyn À/À mice. Samples were fixed in buffered formalin and embedded in paraffin. Sections (4 mm thickness) were stained with hematoxylin-eosin and examined by light microscopy.
Peripheral blood was collected from anesthetized mice by cardiac draw, and platelet counts were determined using Horiba ABX (Horiba Diagnostics, Montpellier, France) and analyzed by inverted light microscopy; cell aliquots were stained with trypan blue and counted by a hemocytometer. Each cell count was performed four times and measurements were performed in triplicate. In vitro colony assays Bone marrow cells were flushed from femurs with IMDM containing 2% heat-inactivated FCS, and single-cell suspensions were prepared under sterile conditions. Marrow cells (1 Â 10 5 ) were cultured in double-chamber slides with MegaCult-C media (StemCell Technologies, Vancouver, Canada) in the presence of rmIL-3 (10 ng/ml, Peprotech) and rmTPO (0, 25, 50, and 75 ng/ml, Peprotech). After culturing for 10-12 days, the slides were dehydrated and colonies were stained for acetylcholinesterase activity. Slides were scored microscopically, and MK colonies (CFU-MKs) were defined as colonies with at least 3-4 MKs.
Immunoprecipitation and Western blot analysis Purified MKs were washed once with ice-cold PBS and lysed in a buffer composed of 50 mM HEPES, pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 1 mM NaVO 4 , 1 mg/ml leupeptin, and 1 mg/ml aprotinin. Whole-cell lysates were obtained by centrifugation at 14 000 g for 15 min at 41C. The protein concentration was determined using the Protein/DC Assay (BioRad) to assure equal loading between lanes. For each sample, 35 mg of total protein was denatured by boiling for 10 min in loading buffer containing a final concentration of 63 mM Tris/base, pH 6.8, 1% b-mercaptoethanol, 1% sodium dodecyl sulfate, and 10% glycerol. Immunoprecipitations were performed with the indicated primary antibodies and incubated overnight at 41C. Immune complexes were collected by adding 25 ml of protein Asepharose beads (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and incubated on a rocker at 41C for 1 h. Beads were washed three times in lysis buffer and then boiled in sample buffer before Western blot analysis. Proteins were sizeseparated on a 4-20% denaturing polyacrylamide gel, transferred to nitrocellulose, blocked with PBS containing 6% BSA, probed with antibodies, and visualized by chemiluminescence as previously described . Quantitations of immunoreactive bands were performed by using the Kodak Image Station 440cf (Rochester, NY, USA).
MAPK and Akt assays MAPK activity in stimulated and unstimulated MK cell lysates was measured as the ability to phosphorylate Elk-1 according to the method previously described (Lannutti and Drachman, 2004) . Akt activity in cell lysates was measured as the ability to phosphorylate GSK-3 fusion peptide. Whole-cell lysate (2005 ml; 250 mg total protein) was incubated overnight at 41C with 155 ml agarose-immobilized Akt (1G1) monoclonal antibody (Cell Signaling Technology). Immunocomplexes were isolated by centrifugation at 41C, and pellets were washed five times with kinase buffer (25 mM Tris-HCl, pH 7.2, 5 mM bglycerolphosphate, 2 mM DTT, 0.1 mM Na 3 VO 4 , 10mM MgCl 2 ). Following the last wash, pellets were resuspended in 505 ml kinase buffer supplemented with 200 mM ATP and 2 mg GSK-3 fusion protein (Cell Signaling Technology). After 30 min at 301C, the reaction was stopped by the addition of SDS sample buffer. Samples were then separated on a 12% polyacrylamide gel, transferred to nitrocellulose, and probed with a phospho-specific GSK-3alpha/beta (Cell Signaling Technology). Membranes were then incubated with goat anti-rabbit IgG coupled to horseradish peroxidase and visualized using enhanced chemiluminescence (Perkin-Elmer Life Sciences, Boston, MA, USA).
